MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.
She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.
MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.
The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.
On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."
The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.
This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.
A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.
These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.
Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:
The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.
It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.
In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.
This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.
Credit: iStock
Belgium has been hit by a Salmonella outbreak linked to contaminated eggs, with more than 300 people falling ill, according to the country’s food safety agency. The outbreak comes after similar Salmonella outbreaks linked to contaminated eggs were reported in the US and UK.
According to the Belgian Federal Agency for the Safety of the Food Chain (FASFC), the outbreak has been linked to eggs produced by Laerco, a company based in Geel in northern Belgium.
“Salmonella is relatively common in Belgium, but we never had such a broad cluster with so many people hit,” an AFSCA spokesperson said.
No deaths have been reported in connection with the Belgian outbreak. However, officials warned that the actual number of cases could be higher, as some people may have experienced mild or no symptoms and did not seek medical testing, BOL News reported.
Also read: UK Food Agency Warns Vulnerable Groups to Avoid Runny Eggs: Who Is At Risk And Which Foods To Avoid
Salmonella was first detected at Laerco’s Geel facility at the end of April. In May, a large-scale recall was launched, with all eggs from the site withdrawn from the market.
The affected products were distributed through several major supermarket chains, including Colruyt, Delhaize, Aldi and Carrefour.
The precautionary recall was also extended to Luxembourg. FASFC notified several other European countries that may have received the eggs, including the Netherlands, France, Italy and Portugal.
As many as 2 million potentially contaminated eggs may have been sold, according to authorities.
AFSCA first discovered the contamination in May and responded by recalling the affected eggs and closing one henhouse at the farm in Flanders.
However, additional cases were reported in the following months. Officials expanded the investigation and closed the entire farm. The poultry were subsequently destroyed after a second egg recall was issued on August 10.
Secondary testing found that the bacteria had spread across multiple sheds despite initial isolation efforts, Euronews reported.
Read More: From Dog Food To Fruit Bars: Over 10 Products Recalled In US Over Contamination
The Belgian outbreak comes after the UK Health Security Agency (UKHSA) linked two deaths and 474 illnesses to three separate Salmonella Enteritidis clusters across the UK.
The US is also experiencing a Salmonella outbreak linked to eggs. The US Food and Drug Administration (FDA) upgraded the recall to its highest risk level and classified nearly 1.6 million dozen eggs as “Class I”, its most serious category for products that could cause serious adverse health consequences or death.
The multistate Salmonella outbreak has been linked to Midwest Poultry Services, L.P. person.
Salmonella is a bacterial infection that commonly causes diarrhea and gastrointestinal illness.
Common symptoms include:
Symptoms usually begin six hours to six days after swallowing the bacteria.
Most people recover from Salmonella infection without medical treatment. However, children, older adults and people with weakened immune systems may develop serious illness requiring medical care.
It can spread through contaminated food, including:
The bacteria can also spread through contact with contaminated environments or from person to person.
Health officials have advised consumers to follow recall instructions and avoid eating affected eggs. UK officials also urged vulnerable people to avoid undercooked or runny eggs, especially when dining out.
Credit: AI
Long hours, jet lag and rapidly changing time-zone are few of the perils of aviation jobs.
Just days after a study revealed that pilots and flight attendants are at a higher cancer risk than the general population, a French court ruled in favour of a former flight attendant, recognising her breast cancer as an occupational disease.
The ruling has exposed the serious risks of exposure to ionising radiation at high altitudes.
A court in Bayonne has recognised former Air France flight attendant Sophie Lainault's breast cancer as an occupational disease, marking the first such ruling for France’s aviation industry.
The court considered her long-term exposure to cosmic radiation, night shifts, and passive smoking during her career that spanned almost three decades.
Lainault, now 59, worked for Air France from 1989 to 2019, first as cabin crew and later as a purser on long-haul flights. She logged more than 12,600 flight hours, including over 6,500 at night.
She told AFP, "It is truly my dearest wish that this opens the way for other women who might not have dared until now."
The higher you travel, the thinner the atmosphere becomes. At commercial cruising altitudes, there is therefore less atmospheric protection against cosmic radiation.
Aircrew can accumulate substantially more occupational radiation exposure than people working at ground level because they spend hundreds or thousands of hours at high altitude during their careers.
The French court specifically cited ionising radiation as one of the occupational factors in Lainault's case.
It also considered night shifts and second-hand smoke, which was particularly relevant because smoking was permitted on Air France flights until 2000.
The ruling does not mean that radiation alone was the reason behind her breast cancer. The court considered several workplace exposures which may have contributed to her diagnosis.
Also read: Daraxonrasib: US FDA Approves Once-Daily Pill for Metastatic Pancreatic Cancer
The ruling comes just days after a study published in JAMA Internal Medicine examined cancer risk among pilots, flight attendants, and other airline staff who spend several hours at high altitudes.
Researchers analysed more than 12.7 million deaths from 2020 to 2024 across 503 occupations. Flight attendants had the highest proportion of deaths from radiation-related cancers, while pilots ranked second.
Radiation-related cancers accounted for approximately 6.9% of deaths among flight attendants and 6.7% among pilots, compared with about 5% in the general working population.
The cancers examined in the study included breast cancer, melanoma, prostate cancer, leukaemia and cancers involving the central nervous system, among others.
The researchers, however, have cautioned against interpreting the findings as proof that cosmic radiation caused these deaths. Aircrew also experiences night work, disrupted circadian rhythms and other occupational exposures, which can contribute.
Also read: ‘Sunscreen Is A Health Essential’: UK Skin Cancer Survivor Urges Govt To Scrap Tax
The recent study speaks about the occupational hazards faced by pilots and flight attendants, who may spend thousands of hours in the air over decades of their careers. That is very different from someone taking a few commercial flights each year. Airline staff who fly regularly are at higher risk due to the cumulative effect of radiation.
Air France said it was not a party to Lainault's case and had not been informed of the court's reasoning but said the “health and safety of employees at work is an absolute priority.”
Credit: iStock
A Phase 3 trial of the new tuberculosis (TB) vaccine candidate VPM1002, sponsored by Pune-based Serum Institute of India, has fallen short of showing that it is as effective as the over 100-year-old BCG vaccine at preventing TB infection in newborns, according to results published in The Lancet Infectious Diseases.
VPM1002 is a live recombinant vaccine created by genetically modifying BCG. It was originally developed in Germany and licensed to the Serum Institute of India.
The trial compared VPM1002 with BCG in newborns across Kenya, Tanzania, Uganda, South Africa and Gabon.
“The results favored BCG over VPM1002 across the efficacy endpoints,” said the research team, which included Videlis Nduba of the Kenya Medical Research Institute and Center for Respiratory Disease Research.
The VPM1002 group had more QFT conversions (184 vs 150), confirmed TB cases (18 vs six), unconfirmed TB cases (92 vs 53) and sustained QFT conversions (44 vs 33), researchers said.
The trial included healthy newborns aged 0–14 days weighing at least 2.3 kg.
The trial recorded only 334 of the 632 planned TB infection events. Researchers also noted that TB blood-test results did not always match confirmed TB infections, while more infants in the VPM1002 group had household TB exposure.
“In this paper, what the researchers have measured is developing ‘TB infection’ after vaccination. This does not mean that all babies had TB disease,” said Dr Swathi Krishna, a TB researcher in Maharashtra who was not part of the study.
“A slightly higher number of babies in the VPM group developed infection as compared to the BCG group. This does not explicitly mean that VPM is inferior to BCG, but it falls short of proving its ability in this particular study,” she told HealthandMe.
BCG, introduced in 1921, remains the only licensed TB vaccine. While it protects children against severe TB, its effectiveness against pulmonary TB in adolescents and adults varies.
VPM1002 is one of 17 TB vaccine candidates in development. TB affected an estimated 10.7 million people and killed 1.2 million globally in 2024.
“There is an urgent need for new tuberculosis vaccines” that are effective across age groups and can be produced at scale, the researchers wrote.
Helen McShane, professor of vaccinology at the University of Oxford, said the findings show that “there are no obvious shortcuts in tuberculosis vaccine efficacy trials.”
A Phase 3 trial published in The British Medical Journal in April found:
© 2024 Bennett, Coleman & Company Limited